Suicide risk assessment tools: what’s the current state of the evidence?

scott-graham-OQMZwNd3ThU-unsplash

Gabrielle Beaudry reviews a new national mixed methods study from the UK on suicide risk assessment tools used in mental health services.

[read the full story...]

Dementia ward inpatients need better protection from COVID-19

shutterstock_1699586842

Clarissa Giebel summarises a recent study on the prevalence, management, and outcomes of COVID-19 infections in older people and dementia patients on mental health wards.

[read the full story...]

Risk factors for self-harm in prison

shutterstock_1469991386

In her debut blog, Rebecca Crook summarises a systematic review of individual and environmental risk factors for self-harm in prison.

[read the full story...]

Antipsychotics versus CBT in first episode psychosis: some answers, more questions

shutterstock_210297724

Joe Pierre summarises two recently published and widely reported RCTs, which suggest that antipsychotic medication might not offer an advantage over psychotherapy in broadly-defined first episode psychosis.

[read the full story...]

Risk and protective factors for childhood suicide: thoughts, plans and behaviours

shutterstock_742597825

In her debut blog, Ellen Townsend summarises a cohort study that explores the risk and protective factors for childhood suicidal thoughts and behaviours.

[read the full story...]

Mental health scientists stand up to COVID-19

toa-heftiba-rdoRdjOk-OY-unsplash

Alexandra Pitman, Sonia Johnson and Michael Bloomfield respond to the mental health and COVID-19 research priorities set out in a new position paper published in The Lancet Psychiatry on 15th April 2020.

[read the full story...]

Cardiovascular risk in severe mental illness: is there a right intervention?

nick-fewings-ka7REB1AJl4-unsplash

A group of Masters Students from the University of Glasgow Global Mental Health MSc write about the Primrose trial, which looked at the clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk in severe mental illness.

[read the full story...]

Risperidone and aripiprazole: genotype, metabolism and dosage

CYP2D6 genotyping before starting treatment might be valuable in clinical practice for individualising risperidone and aripiprazole treatment.

Dolly Sud writes her debut elf blog on a recent retrospective analysis, which compares dose changes of risperidone and aripiprazole with patients’ individual genotype.

[read the full story...]

Suicidality in India: findings from a national cross sectional study

shutterstock_1308483901

In her debut blog, Dee Knipe summarises a national cross-sectional study recently published in The Lancet Psychiatry, which found that more than 44 million adults in India could experience suicidality.

[read the full story...]

Cancer screening disparities in people with mental illness

national-cancer-institute-L7en7Lb-Ovc-unsplash

Emily Peckham from the Closing The Gap Network writes her debut blog on a new systematic review, which finds that people with mental illnesses were less likely to receive screening for cancer compared to the general population.

[read the full story...]